🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the potential of using valsartan/HCT...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-11
Trial ID
NCT00273299
Treatments Being Tested
This is a double-blind study to evaluate the reduction in systolic blood pr...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2005-12
Trial ID
NCT00280540
Treatments Being Tested
The population for this current study will include stage 1 and stage 2 hype...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00304226
Treatments Being Tested
The purpose of the study is to determine whether a specific training of Gen...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00171444
Treatments Being Tested
To evaluate the efficacy of valsartan 160 mg/HCTZ 25 mg in patients not ade...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00171015
Treatments Being Tested
Hypertension is a major global health problem, affecting about 30% of peopl...
Status
Completed
Location
Department of Cardiology
Start Date
2025-11-01
Trial ID
NCT07544888
Treatments Being Tested
A multi-center, randomized, double-blind, phase IV clinical trial to compar...
Status
Completed
Location
Gachon University Gil Hospital
Start Date
2015-03-16
Trial ID
NCT02433119
Treatments Being Tested
The purpose of the study is to evaluate the safety and efficacy of initial ...
Status
Completed
Location
Investigative site
Start Date
2008-04
Trial ID
NCT00698646
Treatments Being Tested
The purpose of this trial is to compare blood pressure lowering efficacy of...
Status
Completed
Location
Egan Healthcare
Start Date
2008-03
Trial ID
NCT00666536
Treatments Being Tested
This study will assess the efficacy of an intensive blood pressure manageme...
Status
Completed
Location
Novartis Pharmaceuticals
Start Date
2009-07
Trial ID
NCT00902304